Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate-Reference-Cited by-同舟云学术

Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate

Published:2023-05-01 Issue:4 Volume:33 Page:134-142
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Childress Ann C.¹^ORCID,Cutler Andrew J.²³,Patel Maitrey⁴,Oh Charles⁴

Affiliation:

1. Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, USA.

2. SUNY Upstate Medical University, Syracuse, New York, USA.

3. Neuroscience Education Institute, Lakewood Ranch, Florida, USA.

4. Corium, LLC, Boston, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2023.0012

Reference12 articles.

1. Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years

2. Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study

3. Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder

4. Long-Term Effects of Methylphenidate Transdermal Delivery System Treatment of ADHD on Growth

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project;Journal of Attention Disorders;2024-02-17

2. Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder;Advances in Pharmacology;2023